| Literature DB >> 33314066 |
Syam Nair1,2,3, Eridan Rocha-Ferreira1,2,3, Bobbi Fleiss4,5, Cora H Nijboer6, Pierre Gressens5, Carina Mallard1,2, Henrik Hagberg1,3.
Abstract
Preclinical studies have shown that mesenchymal stem cells have a positive effect in perinatal brain injury models. The mechanisms that cause these neurotherapeutic effects are not entirely intelligible. Mitochondrial damage, inflammation, and reactive oxygen species are considered to be critically involved in the development of injury. Mesenchymal stem cells have immunomodulatory action and exert mitoprotective effects which attenuate production of reactive oxygen species and promote restoration of tissue function and metabolism after perinatal insults. This review summarizes the present state, the underlying causes, challenges and possibilities for effective clinical translation of mesenchymal stem cell therapy.Entities:
Keywords: inflammation; intraventricular hemorrhage; mesenchymal stem cells; mitochondria; mitophagy; neonatal brain injury; neonatal hypoxia-ischemia; reactive oxygen species
Year: 2021 PMID: 33314066 DOI: 10.1111/jnc.15267
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372